Journal article
Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Abstract
PURPOSE OF REVIEW: Use of gadolinium-based contrast agents (GBCA) in renal impairment is controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic kidney disease (CKD), and dialysis because of concerns regarding nephrogenic systemic fibrosis (NSF). The position that GBCA are absolutely contraindicated in AKI, category G4 and G5 CKD (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2), and …
Authors
Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Maralani PJ; Shabana W; Tang A; Tsampalieros A
Journal
Canadian Journal of Kidney Health and Disease, Vol. 5, ,
Publisher
SAGE Publications
Publication Date
January 1, 2018
DOI
10.1177/2054358118778573
ISSN
2054-3581